Skip to content

A Comparison of the Post-operative analgesic effects of Propofol anaesthesia with Sevoflurane anaesthesia

A Comparison of the Post-operative analgesic effects of Propofol anaesthesia with Sevoflurane anaesthesia

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-001052-48-IE
Enrollment
80
Registered
2008-03-03
Start date
2008-06-10
Completion date
Unknown
Last updated
2025-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute post-operative pain MedDRA version: 9.1 Level: LLT Classification code 10066714 Term: Acute pain MedDRA version: 9.1 Level: LLT Classification code 10036286 Term: Post-operative pain

Interventions

Trade Name: Diprivan Product Name: Diprivan Product Code: Propofol Pharmaceutical Form: Intravenous infusion INN or Proposed INN: PROPOFOL CAS Number: 2078548 Current Sponsor code: Propofol-1 Other de

Sponsors

Coombe Women and Infants University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologist classification I and II patients; aged over 18 years undergoing laparoscopic day case surgery. Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Chronic pain states; known allergies or contraindications to the study medications; lack of informed consent; currently pregnant; currently breast feeding

Design outcomes

Primary

MeasureTime frame
Main Objective: To determine if intravenous propofol anaesthesia compared to inhalational sevoflurane has a postoperative analgesic effect in the immediate postoperative period.;Secondary Objective: To determine if intravenous propofol anaesthesia has a better quality of recovery compared to inhalational sevoflurane.;Primary end point(s): Pain score 0-10 measured on a visual analogue scale. Cumulative morphine consumption. Sedation score Quality of recovery score (QoR-9 and QoR-40 scores)

Countries

Ireland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026